Aichi Cancer Center Hospital ( Site 1610)

Nagoya, Aichi-ken 464-8681

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Cancer

Studies at this site

• Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). — Running, not enrolling